InsiderTrades

Form 4 for ALZN Alzamend Neuro, Inc.

Accepted 2024-01-09 00:00:00 ET · period of report 2024-01-05 · accession 0001214659-24-000495 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
I 2024-01-09 2024-01-05 ALZN AULT MILTON C III Dir, 10% P - Purchase $1.02 +5,000 768.4K +0.7% +$5,100

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-01-05 P A 5,000 $1.02 768,365 I By Ault Lending, LLC — — (F1) Includes 26,032 shares of common stock previously owned by, and received from, Ault Alpha LP ("Ault Alpha"), in connection with the liquidation of Ault Alpha on December 28, 2023. Those 26,032 shares were previously reported as beneficially owned by Mr. Ault as Ault Alpha also reported as an indirect beneficial ownership under Mr. Ault, so no change in beneficial ownership of those shares occurred in connection with the liquidation. (F2) Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Alliance, Inc. ("AAI"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.